Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel
Clinical trial NCT00705835 · COMPLETED
Trial details
- NCT number
- NCT00705835
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2008-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.